Search - tctmd.com

Displaying 21 - 35 of 35

Sort: Relevancy | Date

Presentation THT 2023

Influence of Body Surface Area, and Ventricular Dimensions on Impella 5.5 Outcomes

Presenter: Muath Bishawi

March 21, 2023

News Conference News THT 2023

PCI’s Role for Patients With HFrEF and Extensive CAD: Experts Debate

Todd Neale

March 20, 2023

Presentation THT 2023

Real-World Outcomes of Impella 5.5 in Patients with Cardiogenic Shock: Analysis of the SURPASS Registry

Presenter: Arman Kilic

March 20, 2023

News Daily News

Cardiogenic Shock Outcomes Markedly Worse in De Novo HF Patients

Caitlin E. Cox

December 09, 2022

News Daily News

Heart Transplantation After Circulatory Death Gives ‘Encouraging’ Results

Yael L. Maxwell

September 30, 2022

News Conference News THT 2022

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

Caitlin E. Cox

February 02, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2020

Shelley Wood

March 02, 2020

News Conference News AHA 2019

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

Shelley Wood

November 11, 2019

News Daily News

There’s No ‘I’ in Shock Team: Multidisciplinary Approach Seems to Pay Dividends

Todd Neale

April 10, 2019

News Conference News AHA 2018

AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City

Shelley Wood

November 05, 2018

News Daily News

Do PVADs and IABPs Offer Similar Survival in High-Risk PCI or Cardiogenic Shock?

Caitlin E. Cox

July 30, 2018

News Industry News

Abiomed Announces European Approval (CE Marking) for Impella 5.5™ and First Patient Treated at University Heart Center Hamburg

April 05, 2018

News Daily News

Impella Heart Pumps Get Expanded Indication for Cardiogenic Shock in Setting of Cardiomyopathy

Todd Neale

February 13, 2018

News Industry News

Abiomed Impella 2.5™and Impella 5.0™ Heart Pumps Receive Regulatory Approval From Japan Ministry of Health, Labor & Welfare

September 27, 2016

News Industry News

UH Case Medical Center first in Ohio to implant new ventricular assist device

June 04, 2015

Advertisement

Influence of Body Surface Area, and Ventricular Dimensions on Impella 5.5 Outcomes

PCI’s Role for Patients With HFrEF and Extensive CAD: Experts Debate

Real-World Outcomes of Impella 5.5 in Patients with Cardiogenic Shock: Analysis of the SURPASS Registry

Cardiogenic Shock Outcomes Markedly Worse in De Novo HF Patients

Heart Transplantation After Circulatory Death Gives ‘Encouraging’ Results

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

TCTMD’s Top 10 Most Popular Stories for February 2020

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

There’s No ‘I’ in Shock Team: Multidisciplinary Approach Seems to Pay Dividends

AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City

Do PVADs and IABPs Offer Similar Survival in High-Risk PCI or Cardiogenic Shock?

Abiomed Announces European Approval (CE Marking) for Impella 5.5™ and First Patient Treated at University Heart Center Hamburg

Impella Heart Pumps Get Expanded Indication for Cardiogenic Shock in Setting of Cardiomyopathy

Abiomed Impella 2.5™and Impella 5.0™ Heart Pumps Receive Regulatory Approval From Japan Ministry of Health, Labor & Welfare

UH Case Medical Center first in Ohio to implant new ventricular assist device

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content